Therapeutic potintial of Tregs transduced with CEA specific CAR in sever asthma
Project/Area Number |
16K09533
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Mie University |
Principal Investigator |
KATO Takuma 三重大学, 医学系研究科, 准教授 (60224515)
|
Co-Investigator(Kenkyū-buntansha) |
王 立楠 三重大学, 医学系研究科, 特任助教(研究担当) (00589484)
宮原 慶裕 三重大学, 医学系研究科, 准教授 (10582083)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | キメラ抗原受容他 / 制御性T細胞 / T細胞輸注療法 / 癌胎児性抗原 / 喘息 / キメラ抗原受容体 / 制御性T細胞 / T細胞輸注療法 / 固形がん / GITRシグナル |
Outline of Final Research Achievements |
Regulatory T cells (Tregs) play an important role not only in immunological self-tolerance but also in various inflammatory diseases. In this study, we explored the possibility that Tregs redirected toward carcinoembryonic antigen (CEA) expressed on lung epithelia have potential to control allergic airway inflammation. Retrovirally transduced Tregs with chimeric antigen receptor (CAR) gene constituting scFv specific to CEA as an ectodomain and signaling domains derived from CD3zeta and CD28 as an endodomain exerted potent regulatory activity in vitro. Using a mouse model of allergic asthma, the effect of adoptively transferred CEA-specific CAR-Tregs on airway inflammation will be examined.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究では、気管支喘息患者の炎症局所、即ち気道上皮に恒常的に発現しているCEAでTregを活性化することで様々な疾患起因アレルゲンに対する過剰免疫応答によって発症する気管支喘息を制御することに特色があり、ステロイドによる炎症抑制作用とは作用機序が異なり、難治性喘息患者に対して有効な新規治療法となり得る。また、免疫抑制は炎症局所に限定し全身性の免疫抑制を伴わないことが期待され、感染症に対する抵抗力を削ぐことが無く、全身的な免疫抑制を伴う治療法に比較して優れた治療法になり得ると考えられる。
|
Report
(4 results)
Research Products
(15 results)
-
[Journal Article] Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.2018
Author(s)
Akahori Y, Wang L, Yoneyama M, Seo N, Okumura S, Miyahara Y, Amaishi Y, Okamoto S, Mineno J, Ikeda H, Maki T, Fujiwara H, Akatsuka Y, Kato T, Shiku H.
-
Journal Title
Blood. 2018 Sep 13;132(11):
Volume: 132
Issue: 11
Pages: 1134-1145
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
[Presentation] Anti-tumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination2018
Author(s)
Akahori Y, Wang L, Yoneyama M, Seo N, Okumura S, Miyahara Y, Amaishi Y, Okamoto S, Mineno J, Ikeda H, Maki T, Fujiwara H, Akatsuka Y, Kato T, Shiku H.
Organizer
日本癌学会
Related Report
-
[Presentation] Anti-tumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination2018
Author(s)
Akahori Y, Wang L, Yoneyama M, Seo N, Okumura S, Miyahara Y, Amaishi Y, Okamoto S, Mineno J, Ikeda H, Maki T, Fujiwara H, Akatsuka Y, Kato T, Shiku H.
Organizer
日本がん免疫学会
Related Report
-
-
-
-
-
-
-